1. Home
  2. TECX vs THW Comparison

TECX vs THW Comparison

Compare TECX & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$30.02

Market Cap

549.5M

Sector

N/A

ML Signal

HOLD

THW

abrdn World Healthcare Fund Shares of Beneficial Interest

HOLD

Current Price

$12.69

Market Cap

516.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECX
THW
Founded
2019
N/A
Country
United States
United States
Employees
60
N/A
Industry
Finance Companies
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
549.5M
516.7M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
TECX
THW
Price
$30.02
$12.69
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$75.20
N/A
AVG Volume (30 Days)
132.7K
91.2K
Earning Date
05-07-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.39
$10.13
52 Week High
$35.99
$13.19

Technical Indicators

Market Signals
Indicator
TECX
THW
Relative Strength Index (RSI) 54.28 55.11
Support Level $27.31 $12.63
Resistance Level $31.39 $12.95
Average True Range (ATR) 1.89 0.27
MACD 0.12 0.01
Stochastic Oscillator 71.39 78.60

Price Performance

Historical Comparison
TECX
THW

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About THW abrdn World Healthcare Fund Shares of Beneficial Interest

Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.

Share on Social Networks: